The frequencies of CD19+CD11c+ B cells and CD38++CD27++ (plasma) cells were increased in SLE patients, but they were not statistically different between the TLR7lo/norm and TLR7hi SLE groups (Supplemental Figures 2E–G). This evidence concerns the gene CD19 and systemic lupus erythematosus.